Olverembatinib
Tier C — Watch / tradeOlverembatinib
Targets：Bcr-Abl, KIT
Indications (approved)：Chronic myeloid leukaemia, 髓系白血病加速期
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| HQP-1351-001 | 90347-66-3 | methyl 3-iodo-4-methylbenzoate |
| HQP-1351-002 | 694499-26-8Available | 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline |
| HQP-1351-003 | 943320-50-1 | 3-iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
| HQP-1351-004 | 1207351-15-2 | - |
| HQP-1351-005 | 1257628-77-5 | - |
| HQP-1351 | 1421783-64-3 | - |
Frequently asked questions
What are the approved indications of Olverembatinib?
Approved indications include: Chronic myeloid leukaemia, 髓系白血病加速期.
When does the Olverembatinib patent expire?
No public expiry year is available for Olverembatinib yet; this page updates once verified.
How many synthesis routes are recorded for Olverembatinib?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Olverembatinib intermediates?
1 intermediate CAS of Olverembatinib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Olverembatinib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27